|
Powered by Cell Signaling Technology |
Site Information |
---|
GATtTAPsLSGkGNP SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 447488 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on CTNNB1: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Hou J, et al. (2020) DACT2 regulates structural and electrical atrial remodeling in atrial fibrillation. J Thorac Dis
32642106 Curated Info |
|
Chen Y, Bodles AM (2007) Amyloid precursor protein modulates beta-catenin degradation. J Neuroinflammation 4, 29
18070361 Curated Info |
|
Bustos VH, et al. (2006) The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1. Proc Natl Acad Sci U S A 103, 19725-30
17172446 Curated Info |
|
Al-Fageeh M, et al. (2004) Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32. Oncogene 23, 4839-46
15064718 Curated Info |
|
Park CS, et al. (2004) Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2. J Biol Chem 279, 19592-9
14985333 Curated Info |
|
Blum CA, et al. (2001) beta-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 22, 315-20
11181454 Curated Info |